Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Kininostatin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 1396KN050/CF
This item is not returnable.
View return policy
Description
Measured by its ability to induce apoptosis of HUVEC human umbilical vein endothelial cells. Colman, R.W. et al. (2001) Arterioscler. Thromb. Vasc. Biol. 21:1427. The ED50 for this effect is 1-7 μg/mL in the presence of 10 ng/mL of rhFGF basic.Specifications
Lyophilized from a 0.2μm filtered solution in PBS. | |
10.5 kDa | |
50μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
3827 | |
Kininostatin | |
E. coli-derived human Kininostatin protein Lys438-Ser531 | |
Unconjugated | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction